A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps
A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps
Active, not recruiting · NCT05866614 · Registry updated 2026-03-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps | Axial Spondyloarthritis, Skin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, Spondylarthritis, Spondylarthropathies, ankylosing spondylitis, ankylosis, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, connective tissue disorder, immune system disorder, musculoskeletal system disorder, psoriasis, psoriatic arthritis, rheumatic disorder, rheumatoid arthritis, skin disorder, spondylitis, vertebral column disorder | Active, not recruiting | Not stated | 2026-03-31 | NCT05866614 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Celltrion | 14 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHU Purpan Hôpital Pierre Paul Riquet | Toulouse | France | 1 |